B-PO04-219 COVID-19 ASSOCIATED BI-DIRECTIONAL VENTRICULAR TACHYCARDIA: DOUBLE WHAMMY
Section snippets
Background
Bidirectional ventricular tachycardia (BiVT) is commonly associated with catecholaminergic polymorphic ventricular tachycardia (CPVT), digoxin toxicity, Anderson-Tawil syndrome, myocarditis, myocardial infarction, aconite poisoning, metastatic cardiac tumors, and certain cardiac channelopathies. Patients with coronavirus disease 2019 (COVID-19) who develop cardiac injury are at increased risk of malignant cardiac arrhythmias. However, BiVT in a setting of COVID-19 has not been reported.
Objective
To describe a case of COVID-19 associated BiVT.
Methods
N/A
Results
A 78 year old gentleman with a history of nonischemic cardiomyopathy, permanent atrial fibrillation (AF, not on digoxin), and CKD III presented with fatigue. He was found to be in AF with heart rates up to 130 bpm and tested positive for COVID-19 (although symptoms were mild). Hospital stay complicated with dual tachycardia episodes - atrial fibrillation with non-sustained runs of BiVT (relevant blood tests were within normal limits except CRP and procalcitonin). Transthoracic echocardiogram
Conclusion
With COVID-19’s predilection towards causing arrhythmia and elevated inflammatory biomarkers, this may have been the culprit for the patient’s bidirectional VT.